GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taisho Pharmaceutical Holdings Co Ltd (OTCPK:TAISF) » Definitions » Shiller PE Ratio

Taisho Pharmaceutical Holdings Co (Taisho Pharmaceutical Holdings Co) Shiller PE Ratio : 27.30 (As of May. 06, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Taisho Pharmaceutical Holdings Co Shiller PE Ratio?

As of today (2024-05-06), Taisho Pharmaceutical Holdings Co's current share price is $1594594594.5946. Taisho Pharmaceutical Holdings Co's E10 for the quarter that ended in Dec. 2023 was $58,401,400.00. Taisho Pharmaceutical Holdings Co's Shiller PE Ratio for today is 27.30.

The historical rank and industry rank for Taisho Pharmaceutical Holdings Co's Shiller PE Ratio or its related term are showing as below:

TAISF' s Shiller PE Ratio Range Over the Past 10 Years
Min: 14.01   Med: 18.99   Max: 99999999.99
Current: 99999999.99

During the past years, Taisho Pharmaceutical Holdings Co's highest Shiller PE Ratio was 99999999.99. The lowest was 14.01. And the median was 18.99.

TAISF's Shiller PE Ratio is not ranked
in the Drug Manufacturers industry.
Industry Median: 25.32 vs TAISF: 99999999.99

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Taisho Pharmaceutical Holdings Co's adjusted earnings per share data for the three months ended in Dec. 2023 was $6,651,319.788. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $58,401,400.00 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Taisho Pharmaceutical Holdings Co Shiller PE Ratio Historical Data

The historical data trend for Taisho Pharmaceutical Holdings Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taisho Pharmaceutical Holdings Co Shiller PE Ratio Chart

Taisho Pharmaceutical Holdings Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.05 18.09 21.08 16.95 16.55

Taisho Pharmaceutical Holdings Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.01 16.55 16.35 18.93 27.41

Competitive Comparison of Taisho Pharmaceutical Holdings Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Taisho Pharmaceutical Holdings Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taisho Pharmaceutical Holdings Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taisho Pharmaceutical Holdings Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Taisho Pharmaceutical Holdings Co's Shiller PE Ratio falls into.



Taisho Pharmaceutical Holdings Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Taisho Pharmaceutical Holdings Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=1594594594.5946/58401400
=27.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taisho Pharmaceutical Holdings Co's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Taisho Pharmaceutical Holdings Co's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=6651319.788/106.8000*106.8000
=6,651,319.788

Current CPI (Dec. 2023) = 106.8000.

Taisho Pharmaceutical Holdings Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 23,710,297.588 95.700 26,460,394.800
201406 21,740,710.875 98.000 23,692,937.974
201409 18,418,776.885 98.500 19,970,815.952
201412 19,689,867.779 97.900 21,479,855.759
201503 20,299,930.645 97.900 22,145,378.885
201506 12,622,354.278 98.400 13,699,872.326
201509 27,445,408.814 98.500 29,758,067.628
201512 30,517,531.960 98.100 33,223,979.749
201603 16,682,649.779 97.900 18,199,254.304
201606 22,283,340.721 98.100 24,259,539.134
201609 32,195,535.068 98.000 35,086,562.707
201612 43,841,235.331 98.400 47,583,779.810
201703 22,631,767.722 98.100 24,638,866.388
201706 16,864,762.911 98.500 18,285,854.608
201709 29,257,239.835 98.800 31,626,247.109
201712 63,958,456.001 99.400 68,719,950.713
201803 24,592,915.581 99.200 26,477,050.242
201806 42,076,323.005 99.200 45,299,912.267
201809 128,214,392.127 99.900 137,070,040.832
201812 39,946,737.683 99.700 42,791,490.316
201903 -12,618,730.785 99.700 -13,517,356.548
201906 34,455,090.984 99.800 36,871,780.732
201909 17,565,557.002 100.100 18,741,273.605
201912 13,789,974.427 100.500 14,654,420.585
202003 11,047,922.628 100.300 11,763,889.698
202006 19,065,944.587 99.900 20,382,811.631
202009 24,765,837.350 99.900 26,476,390.680
202012 14,167,321.803 99.300 15,237,361.214
202103 -4,227,265.911 99.900 -4,519,239.232
202106 3,620,550.136 99.500 3,886,178.437
202109 7,847,604.869 100.100 8,372,869.131
202112 26,644,318.119 100.100 28,427,704.047
202203 11,660,485.050 101.100 12,317,901.121
202206 14,138,721.532 101.800 14,833,157.757
202209 11,925,032.959 103.100 12,352,992.435
202212 24,761,330.855 104.100 25,403,555.575
202303 -4,743,226.127 104.400 -4,852,265.808
202306 10,162,063.582 105.200 10,316,619.682
202309 6,959,991.883 106.200 6,999,313.871
202312 6,651,319.788 106.800 6,651,319.788

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Taisho Pharmaceutical Holdings Co  (OTCPK:TAISF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Taisho Pharmaceutical Holdings Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Taisho Pharmaceutical Holdings Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Taisho Pharmaceutical Holdings Co (Taisho Pharmaceutical Holdings Co) Business Description

Traded in Other Exchanges
Address
3-24-1 Takada, Toshima-ku, Tokyo, JPN, 170-8655
Taisho Pharmaceutical Holding Co Ltd is a specialty and generic drug manufacturing company. The company maintains two operational segments, Self-Medication and Prescription Pharmaceuticals. The vast majority of Taisho's revenue is derived from its Self-Medication segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The vast majority of sales are generated by sales to external customers in Japan.

Taisho Pharmaceutical Holdings Co (Taisho Pharmaceutical Holdings Co) Headlines

No Headlines